Orexo AB Company Profile

01:25 EDT 25th March 2018 | BioPortfolio

We start by matching unmet patient needs with the unrealized potential in many existing compounds. We create novel pharmaceuticals, at lower development cost and risk, with shorter time to market.
The right time for a great concept
What if it were possible to take good drugs with high commercial value and make them even better? Not just through minor reformulations or patent extensions, but by adding innovative properties that really benefit patients? This is precisely what a Swedish physician and his colleagues asked themselves in 1995 when they founded Orexo.
Since then, Orexo has become a progressive, fast-growing pharmaceutical company. We’re product-focused, not platform-driven, and we have a proven track record.
Our approach is to develop proprietary pharmaceuticals to address areas of unmet therapeutic need. We do this by using a stepwise synergy process: First we assess areas of need. Then we work to meet the need by combining existing substances with our proprietary drug delivery technologies and unique expertise in dry pharmaceutical formulations.


P.O. Box 303
SE-751 05


Phone: 46 (0)18 780 88 00
Fax: 46 (0)18 780 88 88

News Articles [11 Associated News Articles listed on BioPortfolio]

Orexo, MundiPharma's Zubsolv approved by EMA

Orexo and MundiPharma were granted marketing authorization by the European Medicines Agency for Zubsolv, or buprenorphine and -More- 

Orexo (ORX) - Revolving around US Zubsolv 2018 positioning

Edison Investment Research - Pharmaceutical & healthcare - Orexo: Orexo’s Q3 highlighted a strong financial quarter. Zubsolv US revenue declines of 15% vs Q316 (Q316 benefited from significant o...

Nasdaq Stockholm AB: Listing of bond loan issued by Orexo AB (publ) on STO Corporate Bonds (796/17)

Nasdaq Stockholm decides to officially list 1 bond loan issued by Orexo AB with effect from 2017-12-01. The instrument will be listed on STO Corporate Bonds. Please find instrument identifiers in t...

Orexo AB ADR 2017 Q4 - Results - Earnings Call Slides

Zubsolv godkänt i Europa

Orexo är redo att lansera substitutionsbehandlingen utanför USA.

EU nod for opioid dependence therapy

The European Medicines Agency has issued a marketing authorisation for Orexo and MundiPharma’s Zubsolv (buprenorphine and naloxone) for opioid dependence.

Zubsolv Receives Authorization for Treatment Of Opioid Dependence in Europe

NewsZubsolv is a sublingual tablet licensed for people with opioid dependence within a framework of medical, social, and psychological treatment. It is the first such therapy to be approved in a choic...

Orexo Discloses More Information About the Improved Market Access Position for Zubsolv® US in 2018

Entering 2018, Zubsolv will have stronger market access position than ever in the US. In the commercial segment Zubsolv's formulary access as from January 1, Read more...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis

This is a phase II study in patients with seasonal allergic rhinitis (SAR) and will compare the effect versus placebo of two different oral doses of BLX-028914 in an allergen challenge mod...

Companies [1 Associated Companies listed on BioPortfolio]

Orexo AB

We start by matching unmet patient needs with the unrealized potential in many existing compounds. We create novel pharmaceuticals, at lower development cost and risk, with shorter time to market. The...

More Information about "Orexo AB" on BioPortfolio

We have published hundreds of Orexo AB news stories on BioPortfolio along with dozens of Orexo AB Clinical Trials and PubMed Articles about Orexo AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Orexo AB Companies in our database. You can also find out about relevant Orexo AB Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record